Back to Wells Fargo & Company Wells Fargo & Company

MRKRMRKR

Showing 8 of 14 quarters

Position history for Wells Fargo & CompanyWells Fargo & Company's holdings in Marker Therapeutics, Inc.

Yes. Wells Fargo holds 232 shares of MRKR (Marker Therapeutics), worth $341, as of its Q2 2026 13F filing. The share count is unchanged from Q1 2026. Wells Fargo has held MRKR since Q1 2023, across 14 quarterly 13F filings.

Current Value

$341

Current Shares

232

Total Value Change

-$313

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
232
0.0%
$3410.0%$1.47
0
2026-Q1
Decreased
232
-4.1%
$3020.0%$1.30
0
2025-Q4
Unchanged
242
0.0%
$3610.0%$1.49
0
2025-Q3
Increased
242
+4.3%
$2160.0%$0.89
8
2025-Q2
Unchanged
232
0.0%
$3550.0%$1.53
0
2025-Q1
Unchanged
232
0.0%
$2850.0%$1.23
0
2024-Q4
Unchanged
232
0.0%
$7220.0%$3.11
0
2024-Q3
Unchanged
232
0.0%
$6540.0%$2.82
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used